FREMONT, Calif., July 31, 2014 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today a commercial partnership with Molecular Pathology Laboratory Network, Inc. (MPLN) with the goal of developing Next-Generation sequencing (NGS) based clinical tests. "One of the...
MPLN is a medical diagnostics firm that provides anatomic pathology, flow cytometry, fluorescence in situ hybridization and cytogenetic testing services.